In Vivo TICE (TransIntestinal Cholesterol Excretion) Measurement in Bile Duct Diverted Patients
试验速览
- 阶段
- 不适用
- 入组人数
- 5
- 试验地点
- 2
- 主要终点
- Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients
研究概览
简要总结
So far, the liver has been the main target for cholesterol elimination. However, several recent studies performed in mice have described a new route of cholesterol excretion, the Trans-Intestinal Cholesterol Excretion or TICE. TICE allows direct elimination of plasma cholesterol in the feces directly via the intestine. Until now, only indirect evidence suggests that TICE is also active in humans, the goal of this proof of concept study is to provide the first proof of its existence in humans by using stable isotopes in patients with bile duct diversion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •External bile duct diverted patients
排除标准
- •Inflammatory bowel disease
- •Renal or hepatocellular insufficiency
- •Primary intestinal tumor
- •Cholangitis or severe sepsis
- •Acute or chronic diarrhea
结局指标
主要结局
Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients
时间窗: Day 3
Measuring trans-intestinal cholesterol excretion in vivo in bile diverted patients
次要结局
未报告次要终点
